Body-weight changes in psoriatic patients on systemic treatment;Variation pondérale chez les patients recevant un traitement systémique pour un psoriasis

Annales de Dermatologie et de Venereologie

Volumn 139, Issue 10, 2012, Pages 649-651

  Forien, M ^a   Mahe E ^a   Sin, C ^a   Marchal, A ^a   Sigal, M L ^a  

^a CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LETTER; PSORIASIS; SYSTEMIC THERAPY; WEIGHT CHANGE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; BODY WEIGHT; COMORBIDITY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; LONG-TERM CARE; MALE; METHOTREXATE; MIDDLE AGED; OBESITY; PSORIASIS; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84868378962     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2012.06.032     Document Type: Letter

References (14)

1. J.M. Gelfand, A.L. Neimann, D. Shin, X. Wang, D.J. Margolis, and A.B. Troxel Risk of myocardial infarction in patients with psoriasis JAMA 296 2006 1735 1741
2. D.M. Sommer, S. Jenisch, M. Suchan, E. Christophers, and M. Weichenthal Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis Arch Dermatol Res 298 2006 321 328
3. M. Augustin, G. Glaeske, M.A. Radtke, E. Christophers, K. Reich, and I. Schäfer Epidemiology and comorbidity of psoriasis in children Br J Dermatol 162 2010 633 636
4. D. Hürlimann, A. Forster, G. Noll, F. Enseleit, R. Chenevard, and O. Distler Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis Circulation 106 2002 2184 2187
5. C. Gonzalez-Juanatey, A. Testa, A. Garcia-Castelo, C. Garcia-Porrua, J. Llorca, and M. Gonzalez-Gay Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long term treatment with anti-tumor necrosis factor alpha antibody Arthritis Rheum 51 2004 447 450
6. J.D. Greenberg, J.M. Kremer, J.R. Curtis, M.C. Hochberg, G. Reed, and P. Tsao Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis Ann Rheum Dis 70 2011 576 582
7. E. Capkin, M. Karkucak, A. Kiris, I. Durmus, K. Karaman, and A. Karaca Anti-TNF-α therapy may not improve arterial stiffness in patients with AS: a 24-week follow-up Rheumatology (Oxford) 51 2012 910 914
8. P. Gisondi, C. Cotena, G. Tessari, and G. Girolomoni Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study J Eur Acad Dermatol Venereol 22 2008 341 344
9. K. Briot, L. Gossec, S. Kolta, M. Dougados, and C. Roux Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment J Rheumatol 35 2008 855 861
10. R. Saraceno, C. Schipani, A. Mazzotta, M. Esposito, L. Di Renzo, and A. De Lorenzo Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis Pharmacol Res 57 2008 290 295
11. M. Esposito, A. Mazzotta, R. Saraceno, C. Schipani, and S. Chimenti Influence and variation of the body mass index in patients treated with etanercept for plaque-type psoriasis Int J Immunopathol Pharmacol 22 2009 219 225
12. W.P. Cawthorn, and J.K. Sethi TNF-alpha and adipocyte biology FEBS Lett 582 2008 117 131
13. X. Chen, K. Xun, L. Chen, and Y. Wang TNF-alpha, a potent lipid metabolism regulator Cell Biochem Funct 27 2009 407 416
14. E. Maury, L. Noël, R. Detry, and S.M. Brichard In vitro hyperresponsiveness to tumor necrosis factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects J Clin Endocrinol Metab 94 2009 1393 1400